Fairmount Funds Management’s Immunovant IMVT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-750,000	Closed	-$28.8M	–	18
2023 Q3	$28.8M	Buy	+750,000	New	+$28.8M	3.46%	11